NYSE: CRL
Charles River Laboratories International insiders
The officers, directors and 10% owners of Charles River Laboratories International, Inc. who hold the most stock, valued at the live CRL price.
$327.93
CRL today −$5.3M (−1.60%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 15
- Their CRL stock
- $214M
- Market value
- $15.71B
- Held by ranked insiders
- 1.36%
Insiders by value of CRL holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | James C. Foster | Director | 233,410 | $76.5M | 0.49% | 1860th |
| 2 | Birgit Girshick | Chief Executive Officer | 79,288 | $26.0M | 0.17% | 4239th |
| 3 | C. Richard Reese | Director | 65,541 | $21.5M | 0.14% | 4907th |
| 4 | Shannon Parisotto | CEVP, Disc & Safety Assessment | 42,997 | $14.1M | <0.1% | 6766th |
| 5 | Robert J. Bertolini | Director | 32,802 | $10.8M | <0.1% | 8315th |
| 6 | Joseph W. LaPlume | EVP, Corp Strategy & Develop | 31,041 | $10.2M | <0.1% | 8661st |
| 7 | Victoria L. Creamer | EVP & Chief People Officer | 30,051 | $9.9M | <0.1% | 8890th |
| 8 | Glenn Coleman | EVP & Chief Financial Officer | 27,762 | $9.1M | <0.1% | 8570th |
| 9 | David R. Smith | Corporate Executive VP & CFO | 25,819 | $8.5M | <0.1% | 9334th |
| 10 | William D. Barbo | Corporate Executive VP & CCO | 25,805 | $8.5M | <0.1% | 9950th |
| 11 | Flavia Pease | Corporate Executive VP & CFO | 17,297 | $5.7M | <0.1% | 10333rd |
| 12 | Martin Mackay | Director | 17,137 | $5.6M | <0.1% | 10778th |
| 13 | Richard F. Wallman | Director | 13,386 | $4.4M | <0.1% | 10537th |
| 14 | Deborah Turner Kochevar | Director | 7,894 | $2.6M | <0.1% | 14319th |
| 15 | Abraham Ceesay | Director | 2,384 | $782K | <0.1% | 6746th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Charles River Laboratories International; see each profile for the filing.